3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
16
Lymphoma, Follicular
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Lymphoma, Mantle-Cell
7
Recurrence
5
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma, B-Cell
5
Neoplasms
4
Leukemia, B-Cell
3
Neoplasm, Residual
2
Burkitt Lymphoma
2
Mature B-Cell Malignancies
1
Lymphatic Diseases
1
Leukemia, Hairy Cell
1
Leukemia
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Cytokine Release Syndrome
1
Interventions
Cyclophosphamide
7
Biopsy
4
mogamulizumab
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Etoposide
3
ruxolitinib
2
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Busulfan
2
tofacitinib
1
tazemetostat
1
talimogene laherparepvec
1
sodium-iodide symporter
1
pembrolizumab
1
hypericin
1
cemiplimab
1
belinostat
1
X-Rays
1
Vorinostat
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
obinutuzumab
×
90 days
×
Clear all
No trials found.